FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163504032> ?p ?o ?g. }

• W3163504032 endingPage "3238" @default.
• W3163504032 startingPage "3226" @default.
• W3163504032 abstract "Axonal degeneration is an early and ongoing event that causes disability and disease progression in many neurodegenerative disorders of the peripheral and central nervous systems. Chemotherapy-induced peripheral neuropathy (CIPN) is a major cause of morbidity and the main cause of dose reductions and discontinuations in cancer treatment. Preclinical evidence indicates that activation of the Wallerian-like degeneration pathway driven by sterile alpha and TIR motif containing 1 (SARM1) is responsible for axonopathy in CIPN. SARM1 is the central driver of an evolutionarily conserved programme of axonal degeneration downstream of chemical, inflammatory, mechanical or metabolic insults to the axon. SARM1 contains an intrinsic NADase enzymatic activity essential for its pro-degenerative functions, making it a compelling therapeutic target to treat neurodegeneration characterized by axonopathies of the peripheral and central nervous systems. Small molecule SARM1 inhibitors have the potential to prevent axonal degeneration in peripheral and central axonopathies and to provide a transformational disease-modifying treatment for these disorders. Using a biochemical assay for SARM1 NADase we identified a novel series of potent and selective irreversible isothiazole inhibitors of SARM1 enzymatic activity that protected rodent and human axons in vitro. In sciatic nerve axotomy, we observed that these irreversible SARM1 inhibitors decreased a rise in nerve cADPR and plasma neurofilament light chain released from injured sciatic nerves in vivo. In a mouse paclitaxel model of CIPN we determined that Sarm1 knockout mice prevented loss of axonal function, assessed by sensory nerve action potential amplitudes of the tail nerve, in a gene-dosage-dependent manner. In that CIPN model, the irreversible SARM1 inhibitors prevented loss of intraepidermal nerve fibres induced by paclitaxel and provided partial protection of axonal function assessed by sensory nerve action potential amplitude and mechanical allodynia." @default.
• W3163504032 created "2021-05-24" @default.
• W3163504032 creator A5002773023 @default.
• W3163504032 creator A5009731881 @default.
• W3163504032 creator A5015441809 @default.
• W3163504032 creator A5043319585 @default.
• W3163504032 creator A5055019000 @default.
• W3163504032 creator A5057423267 @default.
• W3163504032 creator A5067233803 @default.
• W3163504032 creator A5068712216 @default.
• W3163504032 creator A5069877730 @default.
• W3163504032 creator A5073009958 @default.
• W3163504032 creator A5075106990 @default.
• W3163504032 creator A5079190905 @default.
• W3163504032 creator A5081774025 @default.
• W3163504032 date "2021-05-08" @default.
• W3163504032 modified "2023-10-11" @default.
• W3163504032 title "Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy" @default.
• W3163504032 cites W1984689348 @default.
• W3163504032 cites W1985287196 @default.
• W3163504032 cites W1992055128 @default.
• W3163504032 cites W1997393571 @default.
• W3163504032 cites W1997441321 @default.
• W3163504032 cites W2029754836 @default.
• W3163504032 cites W2033327073 @default.
• W3163504032 cites W2033655929 @default.
• W3163504032 cites W2050841687 @default.
• W3163504032 cites W2060729604 @default.
• W3163504032 cites W2062200458 @default.
• W3163504032 cites W2064336019 @default.
• W3163504032 cites W2067941866 @default.
• W3163504032 cites W2077496901 @default.
• W3163504032 cites W2090526810 @default.
• W3163504032 cites W2114546997 @default.
• W3163504032 cites W2121836743 @default.
• W3163504032 cites W2136128469 @default.
• W3163504032 cites W2165908983 @default.
• W3163504032 cites W2277158176 @default.
• W3163504032 cites W2526709841 @default.
• W3163504032 cites W2537687146 @default.
• W3163504032 cites W2602599682 @default.
• W3163504032 cites W2613942025 @default.
• W3163504032 cites W2727444613 @default.
• W3163504032 cites W2763323059 @default.
• W3163504032 cites W2792467059 @default.
• W3163504032 cites W2809275210 @default.
• W3163504032 cites W2938071173 @default.
• W3163504032 cites W2969268623 @default.
• W3163504032 cites W2969526404 @default.
• W3163504032 cites W2969806071 @default.
• W3163504032 cites W2972021654 @default.
• W3163504032 cites W2973613538 @default.
• W3163504032 cites W2979492690 @default.
• W3163504032 cites W2981440322 @default.
• W3163504032 cites W2983289313 @default.
• W3163504032 cites W3007223603 @default.
• W3163504032 cites W3007315125 @default.
• W3163504032 cites W3010352845 @default.
• W3163504032 cites W3017005721 @default.
• W3163504032 cites W3017258409 @default.
• W3163504032 cites W3038722185 @default.
• W3163504032 cites W3119346562 @default.
• W3163504032 cites W4296759768 @default.
• W3163504032 doi "https://doi.org/10.1093/brain/awab184" @default.
• W3163504032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8634121" @default.
• W3163504032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33964142" @default.
• W3163504032 hasPublicationYear "2021" @default.
• W3163504032 type Work @default.
• W3163504032 sameAs 3163504032 @default.
• W3163504032 citedByCount "64" @default.
• W3163504032 countsByYear W31635040322021 @default.
• W3163504032 countsByYear W31635040322022 @default.
• W3163504032 countsByYear W31635040322023 @default.
• W3163504032 crossrefType "journal-article" @default.
• W3163504032 hasAuthorship W3163504032A5002773023 @default.
• W3163504032 hasAuthorship W3163504032A5009731881 @default.
• W3163504032 hasAuthorship W3163504032A5015441809 @default.
• W3163504032 hasAuthorship W3163504032A5043319585 @default.
• W3163504032 hasAuthorship W3163504032A5055019000 @default.
• W3163504032 hasAuthorship W3163504032A5057423267 @default.
• W3163504032 hasAuthorship W3163504032A5067233803 @default.
• W3163504032 hasAuthorship W3163504032A5068712216 @default.
• W3163504032 hasAuthorship W3163504032A5069877730 @default.
• W3163504032 hasAuthorship W3163504032A5073009958 @default.
• W3163504032 hasAuthorship W3163504032A5075106990 @default.
• W3163504032 hasAuthorship W3163504032A5079190905 @default.
• W3163504032 hasAuthorship W3163504032A5081774025 @default.
• W3163504032 hasBestOaLocation W31635040321 @default.
• W3163504032 hasConcept C105702510 @default.
• W3163504032 hasConcept C134018914 @default.
• W3163504032 hasConcept C142724271 @default.
• W3163504032 hasConcept C169760540 @default.
• W3163504032 hasConcept C2776925932 @default.
• W3163504032 hasConcept C2779134260 @default.
• W3163504032 hasConcept C2779530196 @default.
• W3163504032 hasConcept C2779683492 @default.
• W3163504032 hasConcept C2779901536 @default.
• W3163504032 hasConcept C2780862704 @default.

• next